Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Heiser

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Nature Biotechnology|June 2, 2014
A community effort to assess and improve drug sensitivity prediction algorithmsJames C Costello, Laura M Heiser, Elisabeth Georgii, et al.
Cancer Research|October 23, 2025
Neoplastic Immune Mimicry Potentiates Breast Tumor ProgressionEric B Berens, Sokchea Khou, Elaine T Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Huizhong Hu, Yen-Chao Wang, et al.
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
Molecular Cancer Research : MCR|August 18, 2019
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast CancerVidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, et al.
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
LSD1 activates a lethal prostate cancer gene network independently of its demethylase functionArchana Sehrawat, Lina Gao, Yuliang Wang, et al.
Nature Communications|November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Nature Communications|September 13, 2023
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast CancerZinab O Doha, Xiaoyan Wang, Nicholas L Calistri, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rinath Jeselsohn, Resel Pereira, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Nature Biotechnology|June 2, 2014
A community effort to assess and improve drug sensitivity prediction algorithmsJames C Costello, Laura M Heiser, Elisabeth Georgii, et al.
Cancer Research|October 23, 2025
Neoplastic Immune Mimicry Potentiates Breast Tumor ProgressionEric B Berens, Sokchea Khou, Elaine T Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Huizhong Hu, Yen-Chao Wang, et al.
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
Molecular Cancer Research : MCR|August 18, 2019
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast CancerVidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, et al.
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
LSD1 activates a lethal prostate cancer gene network independently of its demethylase functionArchana Sehrawat, Lina Gao, Yuliang Wang, et al.
Nature Communications|November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Nature Communications|September 13, 2023
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast CancerZinab O Doha, Xiaoyan Wang, Nicholas L Calistri, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rinath Jeselsohn, Resel Pereira, et al.
Pageof 10